Literature DB >> 9351165

The latent class model for multiple binary screening tests.

T S Lau1.   

Abstract

Given multiple binary tests, such as repeated application of a blind screening test to each individual in a sample, we attempt to estimate the prevalence, sensitivity and specificity of the test without knowing the true disease status of those tested (gold standard). This problem is equivalent to finding the mixing distribution of a mixture of binomial distributions. We suggest a new method to determine the number of latent classes. Our simulations show that the coverage probabilities of the bootstrap confidence intervals of our estimates are correct. Our methods are illustrated by examples from published medical research.

Mesh:

Year:  1997        PMID: 9351165     DOI: 10.1002/(sici)1097-0258(19971030)16:20<2283::aid-sim658>3.0.co;2-t

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

Review 1.  Estimation of diagnostic test accuracy without full verification: a review of latent class methods.

Authors:  John Collins; Minh Huynh
Journal:  Stat Med       Date:  2014-06-09       Impact factor: 2.373

2.  How we determined the most reliable solid medium for studying treatment of tuberculosis.

Authors:  Charles M Heilig; Pei-Jean I Feng; Moses L Joloba; John L Johnson; Karen Morgan; Phineas Gitta; W Henry Boom; Harriet Mayanja-Kizza; Kathleen D Eisenach; Lorna Bozeman; Stefan V Goldberg
Journal:  Tuberculosis (Edinb)       Date:  2014-03-04       Impact factor: 3.131

3.  Use of latent class models to accommodate inter-laboratory variation in assessing genetic polymorphisms associated with disease risk.

Authors:  Stephen D Walter; Eduardo L Franco
Journal:  BMC Genet       Date:  2008-08-08       Impact factor: 2.797

4.  Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis.

Authors:  Stephen D Walter; Corinne A Riddell; Tatiana Rabachini; Luisa L Villa; Eduardo L Franco
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.